Eximo Medical Ltd.

4 articles about Eximo Medical Ltd.

• Eximo Medical Ltd. Announces the First Successful Use of the B-Laser™ Atherectomy System in Crossing Chronic Total Occlusion (CTO) without a guidewire

  5/13/2019

  The therapy of highly complex, chronically occluded arteries in patients suffering from PAD often requires highly skilled interventionists and dedicated endovascular devices that add significant burden to the episode of care.

• Eximo Medical Ltd. Announces First Commercial Case of Its B-Laser™ Atherectomy System in the U.S. and Publication of Its IDE and CE Studies Results

  1/28/2019

  Eximo Medical Ltd., announced the successful launch and first commercial use of the B-Laser™ Atherectomy System for treatment of peripheral vascular disease.

• Eximo Medical Receives FDA Clearance for B-Laser™ Atherectomy System to Treat Peripheral Artery Disease (Including ISR)

  10/8/2018

  The B-Laser Atherectomy System is intended for use in the treatment, including atherectomy, of infrainguinal stenoses and occlusion, including in-stent resteno

• Eximo Medical, An Accelmed Portfolio Company, Announces The Successful Completion Of A Multi-Center First-In-Human Trial In Europe With A Hybrid Catheter For Treating Complex Lesions In Peripheral Blood Vessels

  4/6/2016